Printer Friendly

Preclinical research: Grape compounds kill colon cancer stem cells.

HERSHEY, Pa., June 19, 2017 -- Compounds from grapes kill colon cancer stem cells, both in a Petri dish and in mice, according to a team of researchers.

The compounds--resveratrol--which are found in grape skins and seeds, could also eventually lead to treatments to help prevent colon cancer, Penn State Hershey Cancer Institute researchers reported.

Colorectal cancer is the second leading cause of cancer-related deaths in the U.S., according to the American Cancer Society.

"The combination of resveratrol and grape seed extract is very effective at killing colon cancer cells," said researcher Jairam K. P. Vanamala. "And what we're learning is the combination of these compounds is not toxic to healthy cells."

The researchers suggest that the findings could pave the way for clinical testing of the compounds on human colon cancer, which is the second most common cancer in women and the third in men.

If successful, the compounds could then be used in a pill to help prevent colon cancer and lessen the recurrence of the disease in colon cancer survivors.

The researchers are particularly interested in targeting stem cells because, according to cancer stem cell theory, cancerous tumors are driven by cancer stem cells.

Cancer stem cells are capable of self-renewal, cellular differentiation and maintain their stem cell-like characteristics even after invasion and metastasis.

When taken separately in low doses, resveratrol and grape seed extract are not as effective against cancer stem cell suppression as when they are combined together, according to the researchers.

The combined effect of grape seed extract and resveratrol may offer clues as to why cultures with a plant-based diet tend to have lower colon cancer rates.

These diets may naturally provide a shotgun approach to cancer prevention by using a wide variety of beneficial compounds to target multiple pathways that cancer stem cells use to survive.

"This also connects well with a plant-based diet that is structured so that the person is getting a little bit of different types of plants, of different parts of the plant and different colors of the plant," said Vanamala. "This seems to be beneficial for not only promoting bacterial diversity, but also preventing chronic diseases and eliminating the colon cancer stem cells."

If successful in human trials, the compounds could be taken in low doses using currently available supplements for grape seed extract and resveratrol, which are also found in wine.

However, there is still more work to do to understand the mechanism behind the anti-cancer properties of the grape extract, as well as other colorful fruits and vegetables.

Further research would be aimed at finding specific anti-cancer compounds and better understanding how those compounds work synergistically to create more effective colon-cancer prevention and treatment strategies.

For the study, the researchers separated 52 mice with colon cancer tumors into three groups, including a control group and groups that were fed either the grape compounds or sulindac, an anti-inflammatory drug.

Sulindac was chosen because a previous study showed it significantly reduced the number of tumors in humans.

The incidence of tumors was suppressed in the mice consuming the grape compounds alone by 50 percent, similar to the rate in the group consuming the diet with sulindac.

Citation: Lavanya Reddivari et al., "Grape compounds suppress colon cancer stem cells in vitro and in a rodent model of colon carcinogenesis," BMC Complementary and Alternative Medicine, 2016; 16 (1) DOI: 10.1186/s12906-016-1254-2

Abstract/Article: Contact: Jairam K. P. Vanamala,
COPYRIGHT 2017 DataTrends Publications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Stem Cells & Cancer
Publication:Stem Cell Research News
Date:Jul 3, 2017
Previous Article:A better way to kill cancer stem cells.
Next Article:Israeli firm files for U.S. patent for 3D bio-printing of organs and tissues.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters